Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000801008 | SCV000940756 | uncertain significance | Methylmalonic acidemia with homocystinuria, type cblJ | 2022-07-14 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 646672). This variant has not been reported in the literature in individuals affected with ABCD4-related conditions. This variant is present in population databases (rs183607306, gnomAD 0.02%). This sequence change replaces serine, which is neutral and polar, with glycine, which is neutral and non-polar, at codon 189 of the ABCD4 protein (p.Ser189Gly). |
Ambry Genetics | RCV003353030 | SCV004052223 | uncertain significance | Inborn genetic diseases | 2023-08-15 | criteria provided, single submitter | clinical testing | The c.565A>G (p.S189G) alteration is located in exon 6 (coding exon 6) of the ABCD4 gene. This alteration results from a A to G substitution at nucleotide position 565, causing the serine (S) at amino acid position 189 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004526030 | SCV005039597 | uncertain significance | not specified | 2024-03-11 | criteria provided, single submitter | clinical testing |